FDA Product Code PGX: Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System
An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients.
Leading manufacturers include Quidel Corporation, Alere Scarborough, Inc. and Cepheid.
FDA 510(k) Cleared Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System Devices (Product Code PGX)
About Product Code PGX - Regulatory Context
510(k) Submission Activity
15 total 510(k) submissions under product code PGX since 2014, with 14 receiving FDA clearance (average review time: 127 days).
Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - PGX Product Code
Recent submissions under PGX have taken an average of 183 days to reach a decision - up from 119 days historically. Manufacturers should account for longer review timelines in current project planning.
PGX devices are reviewed by the Microbiology panel. Browse all Microbiology devices →